# Association between obesity and neurodevelopmental delay risk in children under five years: A study from Tumbes, Peru

**Authors:** Miriam Arredondo-Nontol, Rodolfo Arredondo-Nontol, Narcisa Reto, Alexis Germán Murillo Carrasco, Elma Izze Magalhães, Elma Izze Magalhães, Elma Izze Magalhães

PMC · DOI: 10.1371/journal.pone.0343815 · 2026-03-06

## TL;DR

This study finds that childhood obesity is linked to a higher risk of neurodevelopmental delays in young children in Peru.

## Contribution

The study introduces a nomogram to estimate neurodevelopmental delay risk based on obesity and other factors in a Latin American context.

## Key findings

- Childhood obesity was independently associated with higher odds of neurodevelopmental delay risk (OR = 2.73).
- The developed nomogram showed acceptable internal discrimination (AUC > 0.7).
- Male sex and older age were associated with increased risk, while caregiver knowledge of feeding showed protection.

## Abstract

Childhood obesity is an emerging public health concern in low- and middle-income countries and may be associated with early neurodevelopmental vulnerability. Evidence on this association during early childhood remains limited, particularly in Latin American settings.

To evaluate the association between childhood obesity and neurodevelopmental delay risk in children under five years of age attending public healthcare facilities in Tumbes, Peru, and to develop a multivariable nomogram for probabilistic risk estimation.

An analytical cross-sectional study was conducted between 2022 and 2024 among children aged 0–59 months receiving care at two EsSalud healthcare facilities in Tumbes. Neurodevelopment was assessed using the Evaluación del Desarrollo Infantil (EDI), classifying children as having normal development, developmental lag, or being at risk of developmental delay. Childhood obesity was defined using WHO weight-for-height standards. Sociodemographic, clinical, and behavioral variables were collected. Associations were evaluated using proportional odds ordinal logistic regression guided by a directed acyclic graph. A nomogram was developed based on the final model and internally validated using bootstrap resampling (1,000 iterations).

The final analytical sample included 431 children; 27% were classified as obese and 19% had anemia. According to the EDI, 58% had normal development, 36% developmental lag, and 6% were at risk of developmental delay. Childhood obesity was independently associated with higher cumulative odds of neurodevelopmental delay risk (OR = 2.73; 95% CI: 1.66–4.51). Male sex and older age group were also associated with increased risk, while higher caregiver knowledge of complementary feeding showed a protective association. Physical activity compliance and anemia were not independently associated in the multivariable model. The nomogram demonstrated acceptable internal discrimination (AUC > 0.7).

Childhood obesity was associated with increased neurodevelopmental delay risk in children under five years of age. An explanation-informed nomogram using routinely available variables may support early risk stratification in primary care, although external validation is required before broader implementation.

## Linked entities

- **Diseases:** obesity (MONDO:0011122), anemia (MONDO:0002280)

## Full-text entities

- **Genes:** GPCPD1 (glycerophosphocholine phosphodiesterase 1) [NCBI Gene 56261] {aka EDI3, GDE5, GDPD6, PREI4}
- **Diseases:** Autism (MESH:D001321), neuroinflammatory (MESH:D000090862), impair (MESH:D060825), reduced attention span (MESH:D001523), Down syndrome (MESH:D004314), dysbiosis (MESH:D064806), dyslipidemia (MESH:D050171), ASD (MESH:D000067877), PA (MESH:C535387), headache (MESH:D006261), otitis (MESH:D010031), conduct disorders (MESH:D019955), metabolic syndrome (MESH:D024821), nutritional disorders (MESH:D009748), Iron deficiency (MESH:D000090463), genetic syndromes (MESH:D030342), Patau syndrome (MESH:D000073839), ACADEMIC EDITOR (MESH:D007859), impaired gross motor skills (MESH:D019957), function (MESH:D003291), overweight (MESH:D050177), mental health problems (MESH:D000076082), developmental lag (MESH:D020179), Obesity (MESH:D009765), insulin resistance (MESH:D007333), congenital heart disease (MESH:D006330), delayed psychomotor and language development (MESH:D007805), Neurodevelopmental Delay (MESH:D006968), ADHD (MESH:D001289), chronic malnutrition (MESH:D044342), hypertension (MESH:D006973), neurodevelopmental vulnerability (MESH:D008607), hypotonia (MESH:D009123), excess (MESH:D006970), Anemia (MESH:D000740), epilepsy (MESH:D004827), cognitive deficits (MESH:D003072), EDI (MESH:D054877), memory impairment (MESH:D008569), Pierre Robin sequence (MESH:D010855), Developmental Delay (MESH:D002658), motor limitations (MESH:D045745), myopathies (MESH:D009135), FEEDING (MESH:D001068), musculoskeletal disorders (MESH:D009140), depression (MESH:D003866)
- **Chemicals:** omega-3 fatty acids (MESH:D015525), PA (MESH:D011478), iron (MESH:D007501), DAG (-), folates (MESH:D005492), steroids (MESH:D013256)
- **Species:** Lactobacillus (genus) [taxon 1578], Homo sapiens (human, species) [taxon 9606], Bifidobacterium (genus) [taxon 1678], Bacteroides (genus) [taxon 816]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12965558/full.md

---
Source: https://tomesphere.com/paper/PMC12965558